Exits

Name Description Eventsort icon Date Acquired By
<a href="http://www.idexx.com" target="_blank">IDEXX Laboratories</a> Products that enhance the ability of veterinarians to economically provide advanced medical care IPO 1991
<a href="http://www.hologic.com" target="_blank">CYTYC</a> Design, development, manufacturing, and marketing of medical devices focused on women's health IPO 1996
<a href="http://www.antigenics.com" target="_blank">Antigenics</a> Technology and products to treat cancers, infectious diseases, and autoimmune disorders IPO 2000
<a href="http://www.celera.com" target="_blank">Celera</a> Sequenced human genome; now focused on therapeutics for cancer and other diseases IPO 2000
<a href="http://www.exactsciences.com/" target="_blank">EXACT Sciences</a> Proprietary technologies for the early detection, monitoring and staging of common cancers IPO 2001
<a href="/www.evotec.com" target="_blank">Renovis</a> Discovery, development and commercialization of druts to treat neurological diseases and disorders IPO 2004
Seres Therapeutics Developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome. IPO 2015
Editas Medicine Leading genome editing company translating its proprietary technology into novel solutions to treat a broad range of genetically-driven diseases. IPO 2016